Please see below to view the coverage details for this session entry.

Thursday, October 25


Venture Capital Panel

Venture capital is an essential component of drug discovery.  Distinguished members of the life science investment community will provide their thoughts on the current state of financing, including what you need to be venture “fundable” and answer questions from the audience.

Thursday October 25, 2012 11:15am - 12:00pm
Ballroom A (9721 Arboretum Boulevard, Austin, TX 78759)

Jacqueline Northcut (Moderator)

Chief Executive Officer, Texas BioAlliance

Josh Bilenker, MD

Partner, Aisling Capital

David Bonita, MD

Principal, Orbimed

Anand Mehra, MD

Partner, Sofinnova Ventures

Robert Weisskoff, PhD

Partner, Fidelity Biosciences

Tim Kutzkey, PhD

Partner, The Column Group